dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate

C51H59N5O14 — CID 164956742

IUPACdimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate
SMILESC=C1C[C@H]2C=Nc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5C=N6)cc(OCCOCCOCCOCC(=O)NC(CC(=O)OC)CC(=O)OC)c4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C51H59N5O14/c1-31-13-37-24-52-42-22-44(33(3)15-40(42)50(60)55(37)26-31)69-28-34-16-35(29-70-46-23-43-41(21-45(46)62-4)51(61)56-27-32(2)14-38(56)25-53-43)18-39(17-34)68-12-11-66-8-7-65-9-10-67-30-47(57)54-36(19-48(58)63-5)20-49(59)64-6/h15-18,21-25,36-38H,1-2,7-14,19-20,26-30H2,3-6H3,(H,54,57)/t37-,38-/m0/s1
InChIKeyQLIGXPARDLYWKF-UWXQCODUSA-N
MW966.05 g/mol
LogP5.17
Rot. Bonds24

About dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate

dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate (PubChem CID 164956742) has the molecular formula C51H59N5O14 and a molecular weight of 966.05 g/mol. Its IUPAC name is dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate.

Molecular Properties

Compound Namedimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate
PubChem CID164956742
Molecular FormulaC51H59N5O14
Molecular Weight966.05 g/mol
Exact Mass965.41
IUPAC Namedimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate
SMILESC=C1C[C@H]2C=Nc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5C=N6)cc(OCCOCCOCCOCC(=O)NC(CC(=O)OC)CC(=O)OC)c4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C51H59N5O14/c1-31-13-37-24-52-42-22-44(33(3)15-40(42)50(60)55(37)26-31)69-28-34-16-35(29-70-46-23-43-41(21-45(46)62-4)51(61)56-27-32(2)14-38(56)25-53-43)18-39(17-34)68-12-11-66-8-7-65-9-10-67-30-47(57)54-36(19-48(58)63-5)20-49(59)64-6/h15-18,21-25,36-38H,1-2,7-14,19-20,26-30H2,3-6H3,(H,54,57)/t37-,38-/m0/s1
InChIKeyQLIGXPARDLYWKF-UWXQCODUSA-N
XLogP5.17
TPSA211.65 Ų
H-Bond Donors1
H-Bond Acceptors16
Rotatable Bonds24
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500966.05
LogP ≤ 55.17
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate?
The IUPAC name of dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate (CID 164956742) is dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate.
What is the SMILES notation for dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate?
The canonical SMILES for dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate is C=C1C[C@H]2C=Nc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5C=N6)cc(OCCOCCOCCOCC(=O)NC(CC(=O)OC)CC(=O)OC)c4)c(C)cc3C(=O)N2C1.
What is the InChIKey of dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate?
The InChIKey is QLIGXPARDLYWKF-UWXQCODUSA-N. The full InChI is InChI=1S/C51H59N5O14/c1-31-13-37-24-52-42-22-44(33(3)15-40(42)50(60)55(37)26-31)69-28-34-16-35(29-70-46-23-43-41(21-45(46)62-4)51(61)56-27-32(2)14-38(56)25-53-43)18-39(17-34)68-12-11-66-8-7-65-9-10-67-30-47(57)54-36(19-48(58)63-5)20-49(59)64-6/h15-18,21-25,36-38H,1-2,7-14,19-20,26-30H2,3-6H3,(H,54,57)/t37-,38-/m0/s1.
What are the key properties of dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate?
dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate has a molecular weight of 966.05 g/mol, XLogP of 5.17, 24 rotatable bonds, 1 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for dimethyl 3-[[2-[2-[2-[2-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenoxy]ethoxy]ethoxy]ethoxy]acetyl]amino]pentanedioate is sourced from PubChem (CID 164956742), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).